Arcturus Therapeutics: Q3 Earnings Snapshot
By AP News
Published - Nov 07, 2024, 04:48 PM ET
Last Updated - Dec 16, 2024, 05:34 PM EST
SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Thursday reported a loss of $6.9 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 26 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 70 cents per share.
The pharmaceutical company posted revenue of $41.7 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $49.2 million.
